Total Payments
$7,640
2024 Payments
$2,141
Companies
59
Transactions
212
Medicare Patients
36,384
Medicare Billing
$5.8M
Payment Breakdown by Category
Food & Beverage$4,075 (53.3%)
Consulting$3,565 (46.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,075 | 206 | 53.3% |
| Consulting Fee | $3,565 | 6 | 46.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $2,284 | 34 | $0 (2024) |
| BeiGene USA, Inc. | $1,255 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $755.53 | 8 | $0 (2024) |
| Merck Sharp & Dohme LLC | $425.41 | 21 | $0 (2024) |
| SOBI, INC | $258.12 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $240.91 | 13 | $0 (2024) |
| Celgene Corporation | $206.15 | 10 | $0 (2024) |
| PFIZER INC. | $133.35 | 7 | $0 (2024) |
| Daiichi Sankyo Inc. | $131.62 | 7 | $0 (2024) |
| GENZYME CORPORATION | $112.87 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,141 | 56 | BeiGene USA, Inc. ($739.82) |
| 2023 | $2,605 | 38 | Janssen Biotech, Inc. ($915.37) |
| 2022 | $1,753 | 43 | Janssen Biotech, Inc. ($1,058) |
| 2021 | $502.88 | 31 | Janssen Biotech, Inc. ($45.31) |
| 2020 | $322.07 | 27 | Janssen Biotech, Inc. ($144.89) |
| 2019 | $170.98 | 8 | Octapharma USA, Inc. ($69.62) |
| 2018 | $84.16 | 7 | NanoString Technologies, Inc. ($23.96) |
| 2017 | $61.46 | 2 | Alexion Pharmaceuticals, Inc. ($50.00) |
All Payment Transactions
212 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $28.62 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/18/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $25.20 | General |
| Category: Oncology | ||||||
| 12/14/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $24.97 | General |
| Category: Hematology | ||||||
| 12/06/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $27.06 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/04/2024 | Astellas Pharma US Inc | Xospata (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: Oncology | ||||||
| 11/27/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $25.36 | General |
| Category: Hematology/Oncology | ||||||
| 11/26/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Oncology | ||||||
| 11/25/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Agios Pharmaceuticals, Inc. | PYRUKYND (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: Genetically Defined Disease | ||||||
| 11/14/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $39.97 | General |
| Category: Oncology | ||||||
| 11/12/2024 | TerSera Therapeutics LLC | Quzyttir (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: Acute Care | ||||||
| 11/11/2024 | Legend Biotech USA Inc. | — | Food and Beverage | In-kind items and services | $26.78 | General |
| 11/08/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $27.79 | General |
| Category: Hematology/Oncology | ||||||
| 11/07/2024 | TAIHO ONCOLOGY, INC. | LONSURF (Drug), INQOVI | Food and Beverage | In-kind items and services | $28.55 | General |
| Category: Oncology | ||||||
| 11/06/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $34.34 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Oncology | ||||||
| 11/01/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: Monoclonal Antibody | ||||||
| 10/31/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $29.50 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/30/2024 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $25.79 | General |
| 10/29/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: Oncology | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | NINLARO (Drug) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | GENZYME CORPORATION | CERDELGA (Drug), CEREZYME | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Genetic Disease | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $24.85 | General |
| Category: Oncology | ||||||
| 10/22/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $15.36 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 50 | 5,426 | 184,407 | $4.3M | $1.1M |
| 2022 | 83 | 10,375 | 264,347 | $6.7M | $2.0M |
| 2021 | 86 | 10,996 | 258,615 | $5.4M | $1.6M |
| 2020 | 83 | 9,587 | 208,094 | $3.6M | $1.2M |
Total Patients
36,384
Total Services
915,463
Medicare Billing
$5.8M
Procedure Codes
302
All Medicare Procedures & Services
302 procedure records from CMS Medicare Utilization — Page 1 of 13
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 18 | 5,400 | $739,800 | $226,097 | 30.6% |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2023 | 23 | 4,478 | $483,624 | $159,541 | 33.0% |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 2023 | 11 | 3,600 | $396,000 | $130,062 | 32.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 548 | 1,155 | $391,545 | $108,444 | 27.7% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 59 | 17,150 | $394,450 | $100,551 | 25.5% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 62 | 5,040 | $257,040 | $93,622 | 36.4% |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | Office | 2023 | 11 | 1,850 | $342,250 | $44,947 | 13.1% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 99 | 95,880 | $383,520 | $38,027 | 9.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 1,182 | 2,987 | $26,883 | $25,091 | 93.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 1,156 | 3,048 | $88,392 | $23,182 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 180 | 180 | $81,540 | $22,429 | 27.5% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 113 | 205 | $77,490 | $21,295 | 27.5% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 11 | 1,100 | $62,700 | $18,323 | 29.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 168 | 347 | $65,583 | $17,258 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 92 | 116 | $54,984 | $16,617 | 30.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 299 | 1,077 | $74,313 | $11,791 | 15.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 45 | 47 | $26,132 | $6,487 | 24.8% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 29 | 91 | $18,746 | $4,931 | 26.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 133 | 224 | $13,216 | $4,002 | 30.3% |
| 99195 | Drawing of blood for a medical problem | Office | 2023 | 30 | 55 | $15,235 | $3,950 | 25.9% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 14 | 2,600 | $13,000 | $3,557 | 27.4% |
| J9025 | Injection, azacitidine, 1 mg | Office | 2023 | 18 | 10,136 | $40,544 | $3,443 | 8.5% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 39 | 152 | $12,008 | $3,411 | 28.4% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 71 | 138 | $11,592 | $3,158 | 27.2% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 88 | 234 | $14,274 | $2,884 | 20.2% |
About Dr. Deborah Glick, M.D
Dr. Deborah Glick, M.D is a Hematology healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962450783.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Deborah Glick, M.D has received a total of $7,640 in payments from pharmaceutical and medical device companies, with $2,141 received in 2024. These payments were reported across 212 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($4,075).
As a Medicare-enrolled provider, Glick has provided services to 36,384 Medicare beneficiaries, totaling 915,463 services with total Medicare billing of $5.8M. Data is available for 4 years (2020–2023), covering 302 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology
- Other Specialties Medical Oncology
- Location Naples, FL
- Active Since 05/04/2006
- Last Updated 11/10/2025
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1962450783
Products in Payments
- BRUKINSA (Drug) $1,255
- TECVAYLI (Biological) $1,037
- CARVYKTI (Drug) $840.00
- CALQUENCE (Drug) $688.48
- KEYTRUDA (Biological) $313.97
- IMBRUVICA (Drug) $278.28
- VONJO (Drug) $229.50
- REBLOZYL (Biological) $166.06
- ZEPZELCA (Drug) $100.65
- DARZALEX (Biological) $92.97
- Xospata (Drug) $91.95
- VENCLEXTA (Drug) $77.87
- WILATE - VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN) (Biological) $69.62
- OPDIVO (Biological) $63.83
- myRisk (Device) $63.18
- PADCEV (Drug) $63.08
- XTANDI (Drug) $60.43
- LONSURF (Drug) $59.64
- Enhertu (Drug) $57.23
- ALUNBRIG (Drug) $55.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Naples
Dr. Zanetta Lamar, M.d, M.D
Hematology — Payments: $26,908
Hematology $26,908
Ferdy Santiago, Md, MD
Hematology — Payments: $13,181
Hematology $13,181
Jennifer Muller, Md, MD
Hematology — Payments: $10,467
Hematology $10,467
Dr. Raju Vaddepally, M.d, M.D
Hematology — Payments: $6,841
Hematology $6,841
Raphael Bosse, Md, MD
Hematology — Payments: $4,157
Hematology $4,157
Xin Yao, M.d, M.D
Hematology — Payments: $2,754
Hematology $2,754